Development of method to evaluate anti-oxidative capability of Kampo in chronic kidney disease

Authors
Category Primary study
Year 2007
INTERVENTION: Treatment group: administration of Hochu‐ekki‐tou (2.5g x 3/day) for 2 or 4 weeks Control group: follow‐up for 2‐4 weeks without administration of Kampo CONDITION: Chronic kidney disease PRIMARY OUTCOME: to evaluate the ability of Kampo to reduce oxidative stress with the use of oxidative/redox tiol compounds or monoclonal antibodies. INCLUSION CRITERIA: chronic kidney disease with serum creatinine level >=2.0mg/dl
Epistemonikos ID: ccd4e3a7744450ae8c86de89e30434c8c0212871
First added on: Aug 21, 2024